Article Information
vol. 8 no. 4
Published By
Online ISSN
History
- Received August 1, 2022
- Accepted August 11, 2022
- Published online December 27, 2022.
Article Versions
- previous version (October 13, 2022 - 06:04).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright ©The authors 2022 This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org
Author Information
- Florian Tran1,2⇑,
- Danielle M.M. Harris1,3,
- Alena Scharmacher1,
- Hanna Graßhoff4,
- Kristina Sterner4,
- Susanne Schinke4,
- Nadja Käding5,
- Jens Y. Humrich4,
- Otávio Cabral-Marques6,7,8,9,10,
- Joana P. Bernardes1,
- Neha Mishra1,
- Thomas Bahmer2,11,
- Jeanette Franzenburg1,12,
- Bimba F. Hoyer13,
- Andreas Glück2,
- Martina Guggeis1,2,
- Alexander Ossysek1,
- Andre Küller14,
- Derk Frank14,15,
- Christoph Lange16,17,18,19,
- Jan Rupp5,
- Jan Heyckendorf2,16,17,20,
- Karoline I. Gaede16,17,20,21,
- Howard Amital22,
- Philip Rosenstiel1,
- Yehuda Shoenfeld22,23,24,
- Gilad Halpert22,
- Avi Z. Rosenberg25,
- Kai Schulze-Forster26,
- Harald Heidecke26,
- Gabriela Riemekasten3,27,28 and
- Stefan Schreiber1,2,28
- 1Institute of Clinical Molecular Biology, Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany
- 2Department of Internal Medicine I, University Medical Center Schleswig-Holstein, Kiel, Germany
- 3Institute for Human Nutrition and Food Science, University Medical Center Schleswig-Holstein, Kiel, Germany
- 4Department of Rheumatology and Clinical Immunology, University Medical Center Schleswig-Holstein, Lübeck, Germany
- 5Department of Infectious Diseases and Microbiology, University Medical Center Schleswig-Holstein, Lübeck, Germany
- 6Department of Immunology, Instituto de Ciencias Biomedicas, Universidade de São Paulo, São Paulo, SP, Brazil
- 7Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, SP, Brazil
- 8Network of Immunity in Infection, Malignancy, and Autoimmunity, Universal Scientific Education and Research Network, Sao Paulo, SP, Brazil
- 9Department of Medicine, Division of Molecular Medicine, University of São Paulo School of Medicine, São Paulo, Brazil
- 10Laboratory of Medical Investigation 29, University of São Paulo School of Medicine, São Paulo, Brazil
- 11LungenClinic Grosshansdorf, Airway Research Center North (ARCN), German Center for Lung Research (DZL), Grosshansdorf, Germany
- 12Institute of Clinical Chemistry, University Medical Center Schleswig-Holstein, Kiel, Germany
- 13Section for Rheumatology, Department of Internal Medicine I, University Medical Center Schleswig-Holstein, Kiel, Germany
- 14Department of Internal Medicine III, University Medical Center Schleswig-Holstein, Kiel, Germany
- 15German Centre for Cardiovascular Research (DZHK), partner site Hamburg, Kiel, Lübeck, Germany
- 16Research Center Borstel, Borstel, Germany
- 17German Center for Infection Research (DZIF), Hamburg-Lübeck-Borstel-Riems, Borstel, Germany
- 18Respiratory Medicine and International Health, University of Lübeck, Lübeck, Germany
- 19Baylor College of Medicine and Texas Children's Hospital, Houston, TX, USA
- 20Airway Research Center North (ARCN), Members of the German Center for Lung Research (DZL), Borstel, Germany
- 21BioMaterialBank Nord, Borstel, Germany
- 22Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Ramat-Gan, Israel
- 23Ariel University, Ariel, Israel
- 24Laboratory of the Mosaic of Autoimmunity, Saint Petersburg State University, Saint-Petersburg, Russia
- 25Department of Pathology, Johns Hopkins University, Baltimore, MD, USA
- 26CellTrend GmbH, Luckenwalde, Germany
- 27Priority Area Asthma and Allergy, Research Center Borstel, Airway Research Center North (ARCN), Members of the German Center for Lung Research (DZL), Borstel, Germany
- 28These authors contributed equally
- Florian Tran (f.tran{at}ikmb.uni-kiel.de)
Funding
BMBF iTREAT project
3TR (IMI2JU)
DFG Research Unit 5042 “miTarget”
Cluster of Excellence 2167 “Precision Medicine in Chronic Inflammation”
RTF-VIState Schleswig-Holstein
COVID-reponse grant
Article usage
Altmetrics
Vol 8 Issue 4
Table of Contents
Increased protease-activated receptor 1 autoantibodies are associated with severe COVID-19
